Ilo E. Leppik
#198,293
Most Influential Person Across History
Ilo E. Leppik's AcademicInfluence.com Rankings
Download Badge
Medical
Why Is Ilo E. Leppik Influential?
(Suggest an Edit or Addition)Ilo E. Leppik's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies (2008) (894)
- Incidence and risk factors in sudden unexpected death in epilepsy (2001) (405)
- Levetiracetam for partial seizures (2000) (376)
- Double-blind study of lorazepam and diazepam in status epilepticus. (1983) (374)
- Epilepsy in the elderly. (2006) (231)
- Lamotrigine clearance during pregnancy (2002) (223)
- Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures (2001) (204)
- Zonisamide: chemistry, mechanism of action, and pharmacokinetics (2004) (200)
- Hyponatremia from oxcarbazepine and carbamazepine (2005) (149)
- Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. 1993. (2001) (147)
- Discontinuation of levetiracetam because of behavioral side effects (2003) (146)
- Efficacy and safety of zonisamide: results of a multicenter study (1993) (139)
- Antiepileptic drug development (1998) (139)
- Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial. (1998) (137)
- Incidence and risk factors in sudden unexpected death in epilepsy: A prospective cohort study (2001) (136)
- Felbamate for partial seizures (1991) (124)
- Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics. (1994) (116)
- Antiepileptic Drug Use in Nursing Home Residents: Effect of Age, Gender, and Comedication on Patterns of Use (1998) (116)
- Cost of refractory epilepsy in adults in the USA (1996) (116)
- Bilateral central macrogyria: Epilepsy, pseudobulbar palsy, and mental retardation—a recognizable neuronal migration disorder (1989) (116)
- Neurologic prognosis after cardiopulmonary arrest (1980) (113)
- Corpus Callosotomy: Clinical and Electroencephalographic Effects (1984) (110)
- Tiagabine: The Safety Landscape (1995) (109)
- Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group. (1997) (107)
- Intravenous phenytoin (1978) (105)
- Antiepileptic Drugs in Development: Prospects for the Near Future (1994) (102)
- Felbamate: Consensus of current clinical experience (2006) (100)
- Salivary levels of anticonvulsants (1977) (86)
- The KEEPER™ 1 KEEPER is a trademark of UCB S.A. 1 trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study (2003) (84)
- Progressive myoclonus epilepsy treated with zonisamide (1988) (82)
- Intravenous phenytoin in acute treatment of seizures (1979) (81)
- Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial (2003) (81)
- Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. (2013) (80)
- Factors associated with antiepileptic drug use among elderly nursing home residents. (2000) (78)
- Issues in the Treatment of Epilepsy (2001) (76)
- Safety of tiagabine: summary of 53 trials (1999) (76)
- Stressful Life Events and with Seizure Frequency in Patients Epilepsy (1994) (75)
- Safety of intravenous valproate (1995) (74)
- Antiepileptic drug use in nursing home admissions (2003) (72)
- Generic substitutions for antiepileptic drugs (1990) (72)
- Variability of total phenytoin serum concentrations within elderly nursing home residents (2003) (72)
- Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy (2019) (72)
- Status epilepticus: The next decade (1990) (66)
- Neurologic prognosis after cardiopulmonary arrest (1981) (64)
- Compliance During Treatment of Epilepsy (1988) (64)
- Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs. (2012) (63)
- Felbamate Increases Phenytoin but Decreases Carbamazepine Concentrations (1988) (63)
- Neurologic prognosis after cardiopulmonary arrest; II. Level of consciousness (1980) (62)
- How to get patients with epilepsy to take their medication. The problem of noncompliance. (1990) (60)
- Optimizing therapy of seizures in women who use oral contraceptives (2006) (58)
- Effect of felbamate on carbamazepine and its major metabolites (1993) (58)
- Tolerability of levetiracetam in elderly patients with CNS disorders (2003) (57)
- Ictus emeticus and the insular cortex (1988) (57)
- Differential Genotype Dependent Inhibition of CYP2C9 in Humans (2008) (57)
- Status Epilepticus and Tiagabine Therapy: Review of Safety Data and Epidemiologic Comparisons (2001) (53)
- Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs (1995) (50)
- Extended‐release antiepileptic drugs: A comparison of pharmacokinetic parameters relative to original immediate‐release formulations (2013) (49)
- Intractable epilepsy in adults. (1992) (49)
- Basic research in epilepsy and aging (2006) (48)
- Double‐blind, placebo‐controlled comparison of zolpidem, triazolam, and temazepam in elderly patients with insomnia (1997) (46)
- Compliance and variability of plasma phenytoin levels in epileptic patients (1979) (46)
- The effect of felbamate on valproic acid disposition (1994) (46)
- Treatment of acute seizures and status epilepticus with intravenous phenytoin. (1983) (46)
- Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures (2007) (45)
- Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics. (2008) (44)
- Lack of Interaction of Gabapentin with Carbamazepine or Valproate (1994) (43)
- A controlled study of progabide in partial seizures (1987) (43)
- Metabolism of Antiepileptic Medication: Newborn to Elderly (1992) (42)
- Epilepsy in the elderly (2010) (40)
- Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy (2008) (39)
- Guidelines for nonemergency use of parenteral phenytoin products: proceedings of an expert panel consensus process. Panel on Nonemergency Use of Parenteral Phenytoin Products. (1999) (38)
- Effect of food on absorption of Dilantin Kapseals and Mylan extended phenytoin sodium capsules (2001) (35)
- Altered phenytoin clearance with febrile illness (1986) (35)
- Epilepsy in the elderly: scope of the problem. (2007) (35)
- Debate: When does a seizure imply epilepsy? (2008) (34)
- Efficacy and safety of perampanel in the subgroup of elderly patients included in the phase III epilepsy clinical trials (2015) (34)
- Familial cerebral cavernous angioma: Clinical analysis of a family and phenotypic classification (1995) (33)
- Anticonvulsant activity of phenobarbital and phenytoin in combination. (1977) (33)
- Valproate and Clonazepam Comedication in Patients with Intractable Epilepsy (1985) (33)
- Practical prescribing and long-term efficacy and safety of zonisamide (2006) (32)
- Intravenous topiramate: Comparison of pharmacokinetics and safety with the oral formulation in healthy volunteers (2013) (32)
- Classification of the Myoclonic Epilepsies (2003) (30)
- Critical re-evaluation of previous preclinical strategies for the discovery and the development of new antiepileptic drugs (2002) (30)
- Gabapentin as add‐on therapy in refractory partial epilepsy (1993) (30)
- Outcomes research: Clinical trials in the elderly (2006) (30)
- Lamotrigine: A six-month, placebo-controlled, safety and tolerance study (1995) (30)
- Monotherapy and polypharmacy. (2000) (29)
- Canine status epilepticus: A translational platform for human therapeutic trials (2011) (29)
- Subjective Efficacy of Zolpidem in Outpatients with Chronic Insomnia (1997) (28)
- The Place of Levetiracetam in the Treatment of Epilepsy (2001) (28)
- The Place of Felbamate in the Treatment of Epilepsy (1995) (28)
- Involuntary movement disorders associated with felbamate (1995) (28)
- Predictors of postoperative memory function after left anterior temporal lobectomy (2002) (27)
- Routine EEG vs. intensive monitoring in the evaluation of intractable epilepsy. (1983) (27)
- Lower phenytoin serum levels in persons switched from brand to generic phenytoin (2004) (27)
- a Double-blind Crossover Evaluation of Progabide in Partial Seizures : 3:15 Pm 8 (1985) (27)
- Clonazepam in the treatment of epilepsy. (1978) (27)
- Prevalence of Appropriate and Problematic Antiepileptic Combination Therapy in Older People in the Nursing Home (2005) (26)
- The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory (2012) (26)
- Characterization of the Time Course of Carbamazepine Deinduction by an Enzyme Turnover Model (2009) (26)
- Population Pharmacokinetics of Valproic Acid Concentrations in Elderly Nursing Home Residents (2007) (26)
- Epilepsy in the Elderly (2006) (26)
- Phenytoin Prodrug: Preclinical and Clinical Studies (1989) (26)
- Paradoxical urinary phenytoin metabolite (S)/(R) ratios in CYP2C19*1/*2 patients (2006) (26)
- Intravenous topiramate: Safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate (2013) (25)
- Pharmacokinetics of Felbamate, a Novel Antiepileptic Drug: Application of Mixed‐Effect Modeling to Clinical Trials (1989) (25)
- Valproic acid doses, concentrations, and clearances in elderly nursing home residents (2004) (25)
- Population Pharmacokinetics of Carbamazepine in Adults with Epilepsy (1998) (25)
- Three New Drugs for Epilepsy: Levetiracetam, Oxcarbazepine, and Zonisamide (2002) (24)
- The tolerability and safety of valproate sodium injection given as an intravenous infusion (1997) (24)
- New Antiepileptic Drug Development: Preclinical and Clinical Aspects. Proceedings of a conference. Miami, Florida, March 1992. (1993) (24)
- Pharmacokinetics of gabapentin in patients treated with phenytoin (1989) (24)
- Seizure‐free Days Observed in Randomized Placebo‐controlled Add‐on Trials with Levetiracetam in Partial Epilepsy (2003) (24)
- Pharmacokinetics of antiepileptic drugs during pregnancy. (1988) (23)
- Intramuscular and rectal therapies of acute seizures (2015) (23)
- Role of New and Established Antiepileptic Drugs (1998) (23)
- Levetiracetam and Partial Seizure Subtypes: Pooled Data from Three Randomized, Placebo‐controlled Trials (2003) (23)
- Choosing an antiepileptic. Selecting drugs for older patients with epilepsy. (2005) (23)
- Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy (2015) (22)
- Intravenous Phenytoin and Phenobarbital: Anticonvulsant Action, Brain Content, and Plasma Binding in Rat (1979) (22)
- Status epilepticus in the elderly (2018) (22)
- Epilepsy, myasthenia gravis, and effect of plasmapheresis on antiepileptic drug concentrations. (1990) (21)
- Primidone kinetics: Effects of concurrent drugs and duration of therapy (1981) (21)
- Prevalence of epilepsy/seizures as a comorbidity of neurologic disorders in nursing homes (2017) (20)
- Phenytoin use in elderly nursing home residents. (2003) (20)
- Workshop on Antiepileptic Drug Trials in Children (1991) (20)
- Epilepsy in the elderly. (2002) (20)
- Eating Epilepsy: EEG and Clinical Study (1986) (19)
- Effects of estradiol and progesterone on seizure sensitivity in oophorectomized DBA/2J mice and C57/EL hybrid mice (1993) (19)
- Antiepileptic medication interactions. (1993) (19)
- Introduction to the International Geriatric Epilepsy Symposium (IGES) (2006) (19)
- Correlation between red cell and free plasma phenytoin levels in renal disease (1976) (19)
- Effect of influenza vaccination on plasma phenytoin concentrations. (1979) (18)
- Ginkgo biloba Use in Nursing Home Elderly with Epilepsy or Seizure Disorder (2006) (18)
- Twin Studies in Epilepsy (1989) (18)
- Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience. (2006) (18)
- Seasonal incidence of phenytoin allergy unrelated to plasma levels. (1985) (17)
- Quality of life of people with epilepsy in the United States. (1998) (16)
- Advances in antiepileptic drug treatments. A rational basis for selecting drugs for older patients with epilepsy. (2004) (16)
- Antiseizure, antidepressant, and antipsychotic medication prescribing in elderly nursing home residents (2017) (16)
- Safety of an IV formulation of carbamazepine (2009) (16)
- Canine status epilepticus treated with fosphenytoin: A proof of principle study (2015) (16)
- Treatment of epilepsy in 3 specialized populations. (2001) (15)
- Population Pharmacokinetics of Unbound and Total Drug Concentrations Following Intravenously Administered Carbamazepine in Elderly and Younger Adult Patients With Epilepsy (2013) (15)
- Carbamazepine-induced dyskinesia and ophthalmoplegia. (1990) (15)
- A double-blind, placebo-controlled study of remacemide hydrochloride in patients with refractory epilepsy following pre-surgical assessment (2002) (14)
- Compliant populations: variability in serum concentrations. (1988) (14)
- Progressive sensory loss one year after bullet injury of spinal cord. (1978) (14)
- Pharmacokinetics and safety of a phenytoin prodrug given i.v. or i.m. in patients. (1990) (14)
- Hepatotoxicity of valproic acid (1979) (14)
- Machine detection of spike-wave activity in the EEG and its accuracy compared with visual interpretation. (1982) (14)
- Epilepsy and the outcomes of pregnancy (1990) (14)
- Increased clearance of phenytoin during infectious mononucleosis. (1979) (14)
- Clinical evaluation of a depth electroencephalography electrode. (1983) (13)
- Advances in pharmacotherapy: recent developments in the treatment of epilepsy (1993) (13)
- Simultaneous Quantification of 13 Cannabinoids and Metabolites in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry in Adult Epilepsy Patients (2019) (13)
- Antiepileptic Medications in Development (1991) (13)
- Treatment of Epilepsy in the Elderly (2001) (12)
- Steady‐state pharmacokinetics and bioavailability of immediate‐release and extended‐release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodology (2015) (12)
- Development of Tolerance to the Side Effects of Primidone (1984) (12)
- Phenytoin Clearances in a Compliant Population: Description and Application (1986) (12)
- Canine status epilepticus: Proof of principle studies (2009) (12)
- Antiepileptic drug trials in the elderly (2006) (11)
- Pharmacokinetics and Saturable Absorption of Gabapentin in Nursing Home Elderly Patients (2017) (11)
- Rapid infusion of sodium valproate in acutely ill children. (2003) (11)
- Treatment of epilepsy in the elderly (2008) (11)
- Third International Congress on Epilepsy, Brain and Mind: Part 1 (2015) (11)
- Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population. (1988) (11)
- Long‐term use of felbamate: Clinical outcomes and effect of age and concomitant antiepileptic drug use on its clearance (2009) (11)
- Pharmacokinetic-pharmacodynamic modelling of intravenous and oral topiramate and its effect on phonemic fluency in adult healthy volunteers. (2015) (11)
- Variability of carbamazepine and valproate concentrations in elderly nursing home residents (2012) (11)
- Challenges of epilepsy in elderly people (2012) (11)
- New antiepileptic medications. (1993) (11)
- Corrigendum to “Outcomes research: Clinical trials in the elderly” [Epilepsy Research 68 (S1) (2006) S71–S76] (2007) (10)
- Intramuscular and intravenous levetiracetam in humans: Safety and pharmacokinetics (2010) (10)
- Analysis of falls in patients with epilepsy enrolled in the perampanel phase III randomized double‐blind studies (2017) (10)
- Zonisamide (1999) (10)
- Antiepileptic Drug Therapy in Children (2012) (10)
- The validity of epilepsy or seizure documentation in nursing homes (2007) (10)
- Electroencephalographic and Clinical Effects of Total Corpus Callosotomy (1985) (10)
- AED doses: from animals to humans. (1998) (10)
- Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy (2016) (10)
- Carbamazepine dose–concentration relationship in elderly nursing home residents (2007) (9)
- Erratum: Lack of interaction of gabapentin with carbamazepine or valproate (Epilepsia (1994) 35 (155-161)) (1994) (9)
- Valproic acid loading during intensive monitoring. (1987) (9)
- Consensus statement on compliance in epilepsy. (1988) (9)
- Use of antiepileptic medications in nursing homes. (2007) (9)
- Lamotrigine pharmacokinetics following oral and stable‐labeled intravenous administration in young and elderly adult epilepsy patients: Effect of age (2018) (8)
- Compatibility and pH variability of four injectable phenytoin sodium products. (1991) (8)
- Rapid and slow release phenytoin in epileptic patients at steady state: Comparative plasma levels and toxicity (1982) (8)
- Phenytoin dosage predictions using population clearances (1982) (8)
- Diplopia and Involuntary Eye Closure in Spontaneous Cerebellar Hemorrhage (1976) (7)
- COEFFICIENT OF VARIATION AS MEASURE OF COMPLIANCE (1978) (7)
- Diagnosis and treatment selection in elderly patients with epilepsy (2006) (7)
- Introduction and Symposium Overview (1992) (7)
- Phenytoin binding and renal transplantation (1984) (7)
- Effect of progabide on serum phenytoin and carbamazepine concentrations. (1987) (6)
- Intractable epilepsy in adults. (2002) (6)
- Excretion of the Principal Urinary Metabolites of Phenytoin and Absolute Oral Bioavailability Determined by Use of a Stable Isotope in Patients With Epilepsy (2011) (6)
- Choosing an antiepileptic (2005) (6)
- Factors in Variability of Serial Gabapentin Concentrations in Elderly Patients with Epilepsy (2017) (6)
- Pharmacokinetic‐Pharmacodynamic Modeling of Intravenous and Oral Topiramate and Its Effect on the Symbol‐Digit Modalities Test in Adult Healthy Volunteers (2016) (6)
- Use of IV fosphenytoin pharmacokinetics to determine the loading dose for a clinical trial of canine status epilepticus (2015) (6)
- Phenytoin and formation of T lymphocyte rosettes. (1980) (5)
- Phenytoin and phenobarbital concentrations in serum: a comparison of Ames Seralyzer with GLC, TDX, and EMIT. (1989) (5)
- Epilepsy and pregnancy. (1987) (5)
- Should single epileptic seizures be treated? (1994) (5)
- Diatrizoate in computed cranial tomography: a quantitative study. (1977) (5)
- Corrigendum to “The KEEPER™ 1 KEEPER is a trademark of UCB S.A. 1 trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study” [Epilepsy Res. 54 (2003) 153–162] (2003) (5)
- Severity of Topiramate-Related Working Memory Impairment Is Modulated by Plasma Concentration and Working Memory Capacity. (2020) (5)
- The role of lamotrigine in the treatment of epilepsy (1998) (5)
- The Relationship Between Urine and Plasma Concentrations of Carbamazepine: Implications for Therapeutic Drug Monitoring (1991) (5)
- Treatment of Epilepsy in Women of Childbearing Potential (1999) (5)
- Safety of an intravenous formulation of lamotrigine (2014) (5)
- Iron supplements in nursing home patients associated with reduced carbamazepine absorption (2018) (4)
- Epileptic Syndromes: Genetic, Diagnostic, and Therapeutic Aspects: Introductory Remarks and Symposium Overview (1990) (4)
- Epilepsy in the elderly (2002) (4)
- Compliance in epilepsy: introduction. (1988) (4)
- Selecting Treatment in Patients with Epilepsy (2000) (4)
- Quantitative Determination of Phenytoin and Phenobarbital in Capillary Blood by Ames Seralyzer (1987) (4)
- Zonisamide, a novel antiepileptic agent (1999) (4)
- Progabide‐Induced Changes in Carbamazepine Metabolism (1988) (4)
- Epilepsy and oral contraceptives. A therapeutic dilemma. (1983) (4)
- Individual Differences in Working Memory Capacity Predict Topiramate-Related Cognitive Deficits (2018) (4)
- Testing Antiepileptic Drugs In Children (1994) (4)
- Co‐Chairman's Introduction (1995) (3)
- Identifying Family History and Substance Use Associations for Adult Epilepsy from the Electronic Health Record (2016) (3)
- Double‐Blind Withdrawal of Phenytoin and Carbamazepine in Patients Treated with Progabide for Partial Seizures (1986) (3)
- Rational monotherapy for epilepsy. (1996) (3)
- Management of epilepsy in older adults: A critical review by the ILAE Task Force on Epilepsy in the elderly (2022) (3)
- Sources of variability in clinical trials of new drugs for epilepsy. (1993) (3)
- An HIV-positive patient with epilepsy (2003) (3)
- Treating epilepsy in the elderly: More art than science (2014) (2)
- Antiepileptic medications. (1990) (2)
- New Treatment for Epilepsy (1997) (2)
- Comprar Epilepsy. A Guide to Balancing Your Life American Academy of Neurology Press Quality of Life Guide Series | Ilo E. Leppik | 9781932603200 | Demos Medical Publishing (2007) (2)
- Intravenous and Intramuscular Allopregnanolone for Early Treatment of Status Epilepticus: Pharmacokinetics, Pharmacodynamics, and Safety in Dogs (2021) (2)
- Phenytoin pharmacokinetics during chronic therapy (1982) (2)
- Advances in antiepileptic drug treatments (PDF) (2004) (2)
- Incidence of Congenital Malformations in Infants Born to Patients with Epilepsy: A Comparison of Pregnancy Registries and Cohort Study Data (S56.003) (2012) (2)
- Antianxiety Agents (Benzodiazepines and other Sedative Hypnotics): Double-blind study of lorazepam and diazepam in status epilepticus (1983) (2)
- Occurrence of Catamenial Epilepsy (1987) (1)
- STATUS EPILEPTICUS (SE) : THE ROLE OF BENZODIAZEPINES (1990) (1)
- Analysis of Falls in Epilepsy Patients with Partial Onset Seizures in Perampanel Phase 3 Trials (P3.272) (2014) (1)
- Medical Management of Seizures in Cerebrovascular Disorders (2015) (1)
- Intravenous administration of phenytoin (1979) (1)
- Effect of Estradiol or Progesterone on Seizures in Ovariectomized DBA/2J Mice (1987) (1)
- New Co-Editors-in-Chief for Epilepsy Research (2006) (1)
- Cost-effective therapies in nursing home patients with epilepsy and seizures. (2002) (1)
- Editorial (1987) (1)
- A Double-Blind, Placebo-Controlled Trial of Progabide in Epilepsy (1987) (1)
- Introductory Remarks and Symposium Overview (1989) (1)
- FIFTH INTERNATIONAL CONGRESS OF HUMAN GENETICS (1976) (1)
- Naturally Occurring Epilepsy and Status Epilepticus in Dogs (2017) (1)
- Clinical manifestation and diagnosis of epilepsy in the elderly (2004) (1)
- New Onset (Incidence) of Epilepsy and Seizures in Nursing Home Residents. (2022) (1)
- Seizures and epilepsy. Understanding the mechanisms, achieving control. (1984) (1)
- Ilo Leppik , a professor of pharmacy and neurology , is conducting pioneering research into the development of novel drugs for the long-term treatment of prolonged , life-threatening seizures (2014) (0)
- Randomized controlled trial of zonisamide for the treatment of partial-onset seizures. Authors' reply (2002) (0)
- A TL1 Team Approach to CNS-Localized Delivery of Glial Cell-Derived Neurotrophic Factor for Treatment of Parkinson ’ s Disease* Dose Finding for Status Epilepticus Treatment by Pharmacokinetic-Pharmacodynamic Modeling using Quantitative EEG in Dogs (2020) (0)
- 77 – Antiseizure Drug Therapy in Children (2017) (0)
- Pharmacological treatment for older adults with epilepsy and comorbid neurodegenerative disorders (2023) (0)
- Central Nervous System: Methods in Clinical Pharmacology 3 (1983) (0)
- The Expanding Role of Genetics in Epilepsy (2003) (0)
- Robert J. Gumnit, MD (1931–2017) (2018) (0)
- Intensive monitoring of seizures in evaluating efficacy of antiepileptic drugs. (1987) (0)
- Antiepileptic Drug Toxicity: An Overview (2019) (0)
- Anticonvulsant activity of phenytoin in combination with phenobarbital (1975) (0)
- Statistical Indiscretion-Reply (1983) (0)
- SS-2-1 Treatment of epilepsy: new directions (1995) (0)
- Treatment of Epilepsy in Three Specialized Populations (2001) (0)
- Improving Epilepsy Care in Older Adults in the Long-Term Care Setting: Effect of Online Medical Education on Risks and Recognition Among Neurologists (P6.289) (2018) (0)
- New Onset Epilepsy/Seizure US Nursing Homes and Co-morbidities, 2003-2007 (2011) (0)
- Antiepileptic Drug Interactions: An Overview (2019) (0)
- Development of tolerance to PHT and CBZ detected by neuropsychological performance (1982) (0)
- MDS Indication of Epilepsy in Elderly Nursing Home Residents (2009) (0)
- Three new drugs for epilepsy (2002) (0)
- Pharmacokinetics and Saturable Absorption of Gabapentin in Nursing Home Elderly Patients (2017) (0)
- A syndrome of collagen vascular disease, spasticity and mental retardation in an inbred kindred (1976) (0)
- New parenteral formulation of carbamazepine (2006) (0)
- Measuring speech and language characteristics of effects of medications on cognition. (2010) (0)
- Reply from the authors: Zonisamide usage (1989) (0)
- Zonisamide usage (1989) (0)
- Intra-resident variability of total and unbound phenytoin concentrations in elderly nursing home residents (2011) (0)
- New antiepileptic drug development (2017) (0)
- Depression in Elderly Nursing Home Residents Taking Antiepileptic Medications (2010) (0)
- The epidemiology of epilepsy in older adults: A narrative review by the ILAE Task Force on Epilepsy in the Elderly (2023) (0)
- 15. Epilepsy co-morbidities in nursing homes: Focus on Alzheimer’s (2010) (0)
- Managing Your Epilepsy (2000) (0)
- Tiagabine : the art of epilepsy care : a satellite symposium to the 21st International Epilepsy Congress, Sydney, Australia, September 2, 1995 (1995) (0)
- Allopregnanolone Pharmacokinetic-Pharmacodynamic Modeling and Simulations in Dogs with Naturally-Occurring Epilepsy (2019) (0)
- Epilepsy and criminality (2013) (0)
- Rapid and slow release phenytoin in epileptic patients at steady state: Assessment of relative bioavailability utilizing Michaelis-Menten parameters (1982) (0)
- Treatment of Epilepsy (1878) (0)
- 4512 Allopregnanolone Dose Finding for Status Epilepticus Treatment by Pharmacokinetic-Pharmacodynamic Modeling using Quantitative EEG in Dogs (2020) (0)
- Periodic spike complexes in kufs disease (1991) (0)
- Intractable epilepsy: Experimental and clinical aspects. Edited By D. Schmidt And P.L. Morselli. New York: Raven Press, 1986 (1987) (0)
- Epilepsy: The Eighth International Symposium (1978) (0)
- Optimal combination therapy with dilantin and phenobarbital (1975) (0)
- Reply (1990) (0)
- PII‐65 (2006) (0)
- The contribution of CYP2C9 and CYP2C19 polymorphisms to phenytoin disposition in persons with epilepsy (2002) (0)
- Making the most of new seizure treatments (1996) (0)
- An association between resting state EEG parameters and the severity of topiramate-related cognitive impairment (2020) (0)
- Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Commentary (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ilo E. Leppik?
Ilo E. Leppik is affiliated with the following schools:
